JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

Journal of Drugs in Dermatology JDD Article About Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

| Case Reports, Featured Articles, Latest News, Medical Derm, The Latest | No Comments
A Single‑Patient Signal That IL‑31 Blockade May Finally Tame The Relentless Itch Of Linear IgA Disease Linear IgA bullous dermatosis can be as much an itch disorder as a blistering…
Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of tinea versicolor among different skin tones

Tune In, Turn Up, and Celebrate — Happy National Podcast Day!

| Featured Articles, Featured Podcast, Latest News, The Latest | No Comments
Join JDD Podcast: Ask the Investigators as we celebrate almost a decade of dermatology insight with our trusted host, Dr. Adam Friedman. If you love learning with a smile, National…
Journal of Drugs in Dermatology JDD Article About A Qualitative Assessment of Chatbots for Common Dermatologic

A Qualitative Assessment of Chatbots for Common Dermatologic

| Featured Articles, Latest News, Social and Technology, The Latest | No Comments
Chatbots in the Waiting Room: How Reliable Are They for Dermatology Patients?  Four consumer chatbots (ChatGPT 4o mini, Microsoft Copilot, Google Gemini Flash 1.5, and Perplexity) were asked about 25…